Philippe Matthias Tscholl

Dr. Philippe Matthias Tscholl

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2009 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PTPhilippe Matthias Tscholl
Philippe Matthias Tscholl
JAJuan M. Alonso
Juan M. Alonso
GDGabriel Dollé
Gabriel Dollé
AJAstrid Junge
Astrid Junge
JDJiri Dvorak
Jiri Dvorak
Background: High use of medication and nutritional supplements has been reported in several sports. Purpose: To document the use of prescribed medication and nutritional supplements in female and male junior, youth, and adult track and field athletes depending on their sports discipline. Study Design: Descriptive epidemiology study. Methods: Analysis of 3 887 doping control forms undertaken during 12 International Association of Athletics Federations World Championships and 1 out-of-competitions season in track and field. Results: There were 6 523 nutritional supplements (1.7 per athlete) and 3 237 medications (0.8 per athlete) reported. Nonsteroidal anti-inflammatory drugs (NSAIDs; 0.27 per athlete, n = 884), respiratory drugs (0.21 per athlete, n = 682), and alternative analgesics (0.13, n = 423) were used most frequently. Medication use increased with age (0.33 to 0.87 per athlete) and decreased with increasing duration of the event (from sprints to endurance events; 1.0 to 0.63 per athlete). African and Asian track and field athletes reported using significantly fewer supplements (0.85 vs 1.93 per athlete) and medications (0.41 vs 0.96 per athlete) than athletes from other continents. The final ranking in the championships was unrelated to the quantity of reported medications or supplements taken. Compared with middle-distance and long-distance runners, athletes in power and sprint disciplines reported using more NSAIDs, creatine, and amino acids, and fewer antimicrobial agents. Conclusion: The use of NSAIDs in track and field is less than that reported for team-sport events. However, nutritional supplements are used more than twice as often as they are in soccer and other multisport events; this inadvertently increases the risk of positive results of doping tests. Clinical Relevance: It is essential that an evidence-based approach to the prescribing of medication and nutritional supplements is adopted to protect the athletes’ health and prevent them from testing positive in doping controls.

8 February 2017 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PTPhilippe Matthias Tscholl
Philippe Matthias Tscholl
FWFlorian Wanivenhaus
Florian Wanivenhaus
SFSandro F. Fucentese
Sandro F. Fucentese
Trochlear dysplasia is one of the most important risk factors for recurrent patellar instability. It is defined on true lateral conventional radiographs (CR) and axial magnetic resonance imaging (MRI). The type of trochlear dysplasia is decisive for surgical treatment; however, low agreement between CR and MRI has been reported. To compare the Dejour classification of trochlear dysplasia on CR and axial MRI using differing levels defined in the literature. Cohort study (diagnosis); Level of evidence, 2. The 4-type classification of trochlear dysplasia by Dejour was used to analyze 228 knees with recurrent patellar dislocations on true lateral CR and axial MRI. The 2-type modification of the Dejour classification was also similarly analyzed. Measurements on axial MRI were performed at 3 different levels: MR1, the most proximal level where the intercondylar notch forms a “Roman arch”; MR2, 3 cm above the joint line; and MR3, the midpatellar height. MR1 was measured at a mean distance of 29 ± 3.5 mm and MR3 at a mean of 38 ± 5.8 mm above the joint line. MR1 and MR2 were always measured on the cartilaginous trochlea, whereas 52% of MR3 was found more proximally. Overall agreement was fair between CR and MR1/MR2 (31.1%/25.4%, respectively) and highest for MR3 (45.2%; P < .01). The highest agreement (81.8%) was found for MR3 with the 2-type trochlear dysplasia classification (low-grade trochlear dysplasia: type A vs high-grade trochlear dysplasia: types B, C, and D) and lower for MR1 (67.5%) and MR2 (62.0%). Trochlear dysplasia measured on CR and MRI shows only fair agreement, especially when the supratrochlear region of the distal femur is not analyzed on axial MRI. MRI analysis that considers the cartilaginous trochlea only tends to underestimate the severity of dysplasia according to Dejour. For a more precise evaluation of trochlear dysplasia, the entire distal femur should be analyzed on axial MRI.

19 May 2018 in Arthroscopy
Verified
Journal Article
Closed access
PTPhilippe Matthias Tscholl
Philippe Matthias Tscholl
LELukas Ernstbrunner
Lukas Ernstbrunner
LPLinda Pedrazzoli
Linda Pedrazzoli
SFSandro F. Fucentese
Sandro F. Fucentese

22 March 2012 in British Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
PTPhilippe Matthias Tscholl
Philippe Matthias Tscholl
JDJiri Dvorak
Jiri Dvorak
Background The use of medication in professional football has previously been shown to defy clinical guidelines. Materials and methods Physicians of the teams who participated at the 2010 FIFA World Cup provided the list of medications used by each player within the 72 h preceding every match. Results During the tournament 71.7% of all players took medication, and 60.3% (444 of 736 players) took painkilling agents at least once. Over a third of players (39.0%) took a painkilling agent before every game. More medications were used during the finals than during the qualifying round of matches (pool games) (0.87±0.09 vs 0.77±0.03, p<0.01). Players from North and South America took almost twice the number of medications than did players from other continents (1.18±0.08 vs 0.64±0.03; p<0.01). Conclusion The use of medication reported by the team physicians in international football competition is increasing. Systematic use – medication for every match – appeared to be the norm in certain teams. This has implications for player health. These data encourage efforts to better understand, and to address, this potential disastrous practice in professional sports.

19 October 2014 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
PTPhilippe Matthias Tscholl
Philippe Matthias Tscholl
AAAlexander Antoniadis
Alexander Antoniadis
TDTobias J. Dietrich
Tobias J. Dietrich
PKPeter P. Koch
Peter P. Koch
SFSandro F. Fucentese
Sandro F. Fucentese

20 December 2019 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
PTPhilippe Matthias Tscholl
Philippe Matthias Tscholl
FWF. Wanivenhaus
F. Wanivenhaus
VCV. Centmaier-Molnar
V. Centmaier-Molnar
RCR. S. Camenzind
R. S. Camenzind
SFS. F. Fucentese
S. F. Fucentese